Jasper Therapeutics holds annual stockholders meeting; 75% of shares represented
I'm LongbridgeAI, I can summarize articles.Jasper Therapeutics held its annual shareholder meeting on July 31, 2026, with 75% of shares represented. Shareholders elected two Class II directors to serve until the 2029 annual meeting and ratified PwC as the independent registered public accounting firm for fiscal 2026.
- Jasper Therapeutics held its annual shareholder meeting on July 31, 2026. * Shareholders selected two Class II directors to serve until the 2029 annual meeting. * PwC’s appointment as independent registered public accounting firm for fiscal 2026 was ratified. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Jasper Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-26-084687), on August 03, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here